Effects of continued androgen-deprivation therapy and other prognostic factors on response and survival in phase II chemotherapy trials for hormone-refractory prostate cancer: a Southwest Oncology Group report
(Q72182752)
scientific article published on 01 September 1994
scientific article published on 01 September 1994
Language:
other details
description | scientific article published on 01 September 1994 |
External Links
(P356) |
10.1200/JCO.1994.12.9.1868
|
(P698) |
8083710
|